Plasma p-tau217 as a biomarker mapping cognitive impairment in Alzheimer's disease.
OBJECTIVE Plasma p-tau217 is a well-established biomarker of Alzheimer disease (AD) pathology, but its relationship with cognitive status and longitudinal cognitive change remains less well characterized. We investigated the clinical relevance of plasma p-tau217 as a blood-based biological correlate of cognitive status...